936
Views
84
CrossRef citations to date
0
Altmetric
Theme: Biomarker Diagnostics - Reviews

Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients

, &
Pages 827-844 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ushma Jaykamal Shah, Ahmad Alsulimani, Faraz Ahmad, Darin Mansor Mathkor, Ahdab Alsaieedi, Steve Harakeh, Mohammad Nasiruddin & Shafiul Haque. (2022) Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications. Biotechnology and Genetic Engineering Reviews 38:2, pages 339-383.
Read now
Athina Markou, Martha Zavridou & Evi S Lianidou. (2015) MicroRNA signatures as clinical biomarkers in lung cancer. Current Biomarker Findings 5, pages 35-45.
Read now
Jiri Polivka$suffix/text()$suffix/text(), Martin Pesta & Filip Janku. (2015) Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?. Expert Review of Molecular Diagnostics 15:12, pages 1631-1644.
Read now
Michael J Donovan & Carlos Cordon-Cardo. (2014) Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers. Expert Review of Molecular Diagnostics 14:8, pages 1023-1031.
Read now

Articles from other publishers (80)

Siyu Fu, José D. Debes & André Boonstra. (2023) DNA methylation markers in the detection of hepatocellular carcinoma. European Journal of Cancer 191, pages 112960.
Crossref
Isabel Anzinger, Dorothea Nagel, Enrico N. De Toni, Andrea Ofner, Alexander B. Philipp, Lesca M. Holdt, Daniel Teupser, Frank T. Kolligs & Andreas Herbst. (2023) Cell-free circulating ALU repeats in serum have a prognostic value for colorectal cancer patients. Cancer Biomarkers 37:4, pages 237-248.
Crossref
Elena Ricciardi, Elena Giordani, Giovanna Ziccheddu, Italia Falcone, Patrizio Giacomini, Maurizio Fanciulli, Michelangelo Russillo, Marianna Cerro, Gennaro Ciliberto, Aldo Morrone, Antonino Guerrisi & Fabio Valenti. (2023) Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach. International Journal of Molecular Sciences 24:4, pages 4014.
Crossref
Qiang Huang, Mengyou Ji, Feiran Li, Yufeng Li, Xuehua Zhou, Chi-yao Hsueh & Liang Zhou. (2023) Diagnostic and prognostic value of plasma cell-free DNA combined with VEGF-C in laryngeal squamous cell carcinoma. Molecular and Cellular Probes 67, pages 101895.
Crossref
Maria Manuel Casteleiro Alves, Luísa Oliani, Micaela Almeida, Henrique José Cardoso, António Hélio Oliani, Luiza Breitenfeld & Ana Cristina Ramalhinho. (2023) Cell-Free DNA as a New Biomarker of IVF Success, Independent of Any Infertility Factor, Including Endometriosis. Diagnostics 13:2, pages 208.
Crossref
Clara Chamba, Sam M. Mbulaiteye, Emmanuel Balandya & Anna Schuh. (2023) Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa. Cambridge Prisms: Precision Medicine 1.
Crossref
Carolina Maria Sassu, Innocenza Palaia, Serena Maria Boccia, Giuseppe Caruso, Giorgia Perniola, Federica Tomao, Violante Di Donato, Angela Musella & Ludovico Muzii. (2021) Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer. International Journal of Molecular Sciences 22:24, pages 13650.
Crossref
Oana Ciobanu, Sorina Martin & Simona Fica. (2021) Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review). Experimental and Therapeutic Medicine 22:6.
Crossref
Yuyuan Zhang, Zaoqu Liu, Kun Ji, Xin Li, Caihong Wang, Zhigang Ren, Yang Liu, Xinju Chen, Xinwei Han, Lingfang Meng, Lifeng Li & Zhen Li. (2021) Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 8.
Crossref
Bo Zheng, Xiao-Long Liu, Rong Fan, Jian Bai, Hao Wen, Lu-Tao Du, Guo-Qing Jiang, Chun-Ying Wang, Xiao-Tang Fan, Yi-Nong Ye, Yun-Song Qian, Ying-Chao Wang, Gao-Jing Liu, Guo-Hong Deng, Feng Shen, He-Ping Hu, Hui Wang, Qing-Zheng Zhang, Lan-Lan Ru, Jing Zhang, Yan-Hang Gao, Jie Xia, Hua-Dong Yan, Min-Feng Liang, Yan-Long Yu, Fu-Ming Sun, Yu-Jing Gao, Jian Sun, Chun-Xiu Zhong, Yin Wang, Fei Kong, Jin-Ming Chen, Dan Zheng, Yuan Yang, Chuan-Xin Wang, Lin Wu, Jin-Lin Hou, Jing-Feng Liu, Hong-Yang Wang & Lei Chen. (2021) The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients. Clinical Cancer Research 27:13, pages 3772-3783.
Crossref
Weina Zhang, Yu-min Zhang, Yuan Gao, Shengmiao Zhang, Weixin Chu, Guopeng Wei, Ke Li, Xuesong He, Long Chen, Li Guo, Shufang Luan & Ping Zhang. (2021) A novel decision tree model based on chromosome imbalances in cell-free DNA and CA-125 in the differential diagnosis of ovarian cancer. The International Journal of Biological Markers 36:2, pages 3-13.
Crossref
Jia Li, Zhaoyan Li, Yajie Ding, Yan Xu, Xiaohong Zhu, Nida Cao, Chen Huang, Mengmeng Qin, Feng Liu & Aiguang Zhao. (2021) TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer. PeerJ 9, pages e11146.
Crossref
Ming Yu, Yu Zhu, Lichen Teng, Jialin Cui & Yajuan Su. (2021) Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?. Journal of Oncology 2021, pages 1-10.
Crossref
Dimitra Stergiopoulou, Athina Markou, Eleni Tzanikou, Ioannis Ladas, G. Mike Makrigiorgos, Vassilis Georgoulias & Evi Lianidou. (2021) ESR1 NAPA Assay: Development and Analytical Validation of a Highly Sensitive and Specific Blood-Based Assay for the Detection of ESR1 Mutations in Liquid Biopsies. Cancers 13:3, pages 556.
Crossref
Juan Pablo Hinestrosa, David J. Searson, Jean M. Lewis, Alfred Kinana, Orlando Perrera, Irina Dobrovolskaia, Kevin Tran, Robert Turner, Heath I. Balcer, Iryna Clark, David Bodkin, Dave S. B. Hoon & Rajaram Krishnan. (2020) Simultaneous Isolation of Circulating Nucleic Acids and EV-Associated Protein Biomarkers From Unprocessed Plasma Using an AC Electrokinetics-Based Platform. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Marco Benati, Martina Montagnana, Elisa Danese, Martina Mazzon, Elisa Paviati, Simone Garzon, Antonio Simone Laganà, Jvan Casarin, Silvia Giudici, Ricciarda Raffaelli, Fabio Ghezzi, Massimo Franchi & Giuseppe Lippi. (2020) Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer. Pathology & Oncology Research 26:4, pages 2281-2289.
Crossref
Hyeon Gi Kye, Christian D. Ahrberg, Byeong Seon Park, Jong Min Lee & Bong Geun Chung. (2020) Separation, Purification, and Detection of cfDNA in a Microfluidic Device. BioChip Journal 14:2, pages 195-203.
Crossref
Anne-Katrin Hickmann, Maximilian Frick, Dirk Hadaschik, Florian Battke, Markus Bittl, Oliver Ganslandt, Saskia Biskup & Dennis Döcker. (2019) Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas. BMC Cancer 19:1.
Crossref
Tuaeva, Falzone, Porozov, Nosyrev, Trukhan, Kovatsi, Spandidos, Drakoulis, Kalogeraki, Mamoulakis, Tzanakakis, Libra & Tsatsakis. (2019) Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells 8:10, pages 1251.
Crossref
Carolina Malhone & Adhemar Longatto-Filho. (2019) Cervical, Ovarian and Endometrial Tumor Markers: Potential Clinical Value. Seminars in Ultrasound, CT and MRI 40:4, pages 350-357.
Crossref
Roxane Mari, Emilie Mamessier, Eric Lambaudie, Magali Provansal, Daniel Birnbaum, François Bertucci & Renaud Sabatier. (2019) Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease. Cancers 11:6, pages 774.
Crossref
Carolyn Hall, Vanessa Sarli, Salyna Meas & Anthony Lucci. (2019) Role of Liquid Biopsy in Clinical Decision-Making for Breast Cancer. Current Breast Cancer Reports 11:2, pages 52-66.
Crossref
Luca Cavallone, Mohammed Aldamry, Josiane Lafleur, Cathy Lan, Pablo Gonzalez Ginestet, Najmeh Alirezaie, Cristiano Ferrario, Adriana Aguilar-Mahecha & Mark Basik. (2019) A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR. Cancer Epidemiology, Biomarkers & Prevention 28:5, pages 909-916.
Crossref
Jiahao Lin, Lie Ma, Di Zhang, Jiafeng Gao, Yipeng Jin, Zhihai Han & Degui Lin. (2019) Tumour biomarkers—Tracing the molecular function and clinical implication. Cell Proliferation 52:3.
Crossref
Alireza Gharatape & Ahmad Yari Khosroushahi. (2019) Optical Biomarker-based Biosensors for Cancer/Infectious Disease Medical Diagnoses. Applied Immunohistochemistry & Molecular Morphology 27:4, pages 278-286.
Crossref
Evi Lianidou & Klaus Pantel. (2019) Liquid biopsies. Genes, Chromosomes and Cancer 58:4, pages 219-232.
Crossref
Liguo Wang, George W. MarekIIIIII, Ryan A. Hlady, Ryan T. Wagner, Xia Zhao, Virginia C. Clark, Alex Xiucheng Fan, Chen Liu, Mark Brantly & Keith D. Robertson. (2019) Alpha‐1 Antitrypsin Deficiency Liver Disease, Mutational Homogeneity Modulated by Epigenetic Heterogeneity With Links to Obesity. Hepatology.
Crossref
Aura D Herrera-Martínez, Leo J Hofland, María A Gálvez Moreno, Justo P Castaño, Wouter W de Herder & Richard A Feelders. (2019) Neuroendocrine neoplasms: current and potential diagnostic, predictive and prognostic markers. Endocrine-Related Cancer 26:3, pages R157-R179.
Crossref
Roxane Mari, Éric Lambaudie, Magali Provansal & Renaud Sabatier. (2019) Apports de l’ADN tumoral circulant dans la compréhension et la prise en charge des carcinomes d’origine gynécologique. Bulletin du Cancer 106:3, pages 237-252.
Crossref
Russell J. Diefenbach, Jenny H. Lee & Helen Rizos. (2018) Monitoring Melanoma Using Circulating Free DNA. American Journal of Clinical Dermatology 20:1, pages 1-12.
Crossref
Xinglu Jiang, Chenggui Zhao, Xiaobo Fan, Wei Xu, Rui Zhang, Hongbo Xu & Guoqiu Wu. (2019) A DNA-modified hydrogel for simultaneous purification, concentration and detection of targeted cfDNA in human serum. RSC Advances 9:6, pages 3407-3415.
Crossref
Ashish Singhal, Akhlak Hussain, Akash Agarwal & Bimlesh Thakur. (2019) Current status of cell-free DNA in head and neck cancer management. Annals of Indian Academy of Otorhinolaryngology Head and Neck Surgery 3:1, pages 1.
Crossref
Yong-Man Kim, Shin-Wha Lee, Young-Jae Lee, Ha-Young Lee, Jong-Eun Lee & Eun-Kyung Choi. (2019) Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma. Journal of Gynecologic Oncology 30:3.
Crossref
Javier I. J. Orozco, Diego M. Marzese & Dave S. B. Hoon. 2019. Handbook of Nutrition, Diet, and Epigenetics. Handbook of Nutrition, Diet, and Epigenetics 483 503 .
Katarina Kalavska, Tomas Minarik, Barbora Vlkova, Denisa Manasova, Michaela Kubickova, Andrej Jurik, Jozef Mardiak, Jozef Sufliarsky, Peter Celec & Michal Mego. (2018) Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients. Journal of Ovarian Research 11:1.
Crossref
Enrico Vizza, Giacomo Corrado, Martina De Angeli, Mariantonia Carosi, Emanuela Mancini, Ermelinda Baiocco, Benito Chiofalo, Lodovico Patrizi, Ashanti Zampa, Giulia Piaggio & Lucia Cicchillitti. (2018) Serum DNA integrity index as a potential molecular biomarker in endometrial cancer. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Selena Y. LinSharon K. HuangKelly T. HuynhMatthew P. SalomonShu-Ching ChangDiego M. MarzeseRichard B. LanmanAmirAli TalasazDave S.B. Hoon. (2018) Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring Disease. JCO Precision Oncology:2, pages 1-30.
Crossref
Sumbal Sumbal, Aneeqa Javed, Bakht Afroze, Hafiza Fizzah Zulfiqar, Faqeeha Javed, Sobia Noreen & Bushra Ijaz. (2018) Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection. Experimental Hematology 65, pages 17-28.
Crossref
Lydia Giannopoulou, Sophia Mastoraki, Paul Buderath, Areti Strati, Kitty Pavlakis, Sabine Kasimir-Bauer & Evi S. Lianidou. (2018) ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer. Gynecologic Oncology 150:2, pages 355-360.
Crossref
Makoto Nakabayashi, Akihiro Kawashima, Rika Yasuhara, Yosuke Hayakawa, Shingo Miyamoto, Chiaki Iizuka & Akihiko Sekizawa. (2018) Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration. Scientific Reports 8:1.
Crossref
Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen & Tingbo Liang. (2018) Liquid biopsy in pancreatic cancer: the beginning of a new era. Oncotarget 9:42, pages 26900-26933.
Crossref
Octav Ginghina & Cornelia Nitipir. 2018. Colorectal Cancer - Diagnosis, Screening and Management. Colorectal Cancer - Diagnosis, Screening and Management.
Sophia Mastoraki, Areti Strati, Eleni Tzanikou, Maria Chimonidou, Eleni Politaki, Alexandra Voutsina, Amanda Psyrri, Vassilis Georgoulias & Evi Lianidou. (2018) ESR1 Methylation: A Liquid Biopsy–Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment . Clinical Cancer Research 24:6, pages 1500-1510.
Crossref
Maryam Eini, Seyed Ali Nojoumi, Mohammad-Amin Saki & Abbas Khosravi. (2017) Cell free nucleic acids as diagnostic and prognostic marker in leukemia. memo - Magazine of European Medical Oncology 11:1, pages 65-70.
Crossref
Abdul Rahim Ferhan, Joshua A. Jackman, Jae Hyeon Park, Nam-Joon Cho & Dong-Hwan Kim. (2018) Nanoplasmonic sensors for detecting circulating cancer biomarkers. Advanced Drug Delivery Reviews 125, pages 48-77.
Crossref
Chao Shi, Yan Zheng, Yin Li, Haibo Sun & Shilei Liu. (2018) Association between clinical characteristics and the diagnostic accuracy of circulating single-molecule amplification and resequencing technology on detection epidermal growth factor receptor mutation status in plasma of lung adenocarcinoma. Journal of Clinical Laboratory Analysis 32:2, pages e22271.
Crossref
Lydia Giannopoulou, Sabine Kasimir-Bauer & Evi S. Lianidou. (2018) Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA. Clinical Chemistry and Laboratory Medicine (CCLM) 56:2, pages 186-197.
Crossref
Ana Barbosa, Ana Peixoto, Pedro Pinto, Manuela Pinheiro & Manuel R. Teixeira. (2018) Potential clinical applications of circulating cell-free DNA in ovarian cancer patients. Expert Reviews in Molecular Medicine 20.
Crossref
Evi Lianidou & Dave Hoon. 2018. Principles and Applications of Molecular Diagnostics. Principles and Applications of Molecular Diagnostics 235 281 .
Luka de Vos, Heidrun Gevensleben, Andreas Schröck, Alina Franzen, Glen Kristiansen, Friedrich Bootz & Dimo Dietrich. (2017) Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients. Clinical Epigenetics 9:1.
Crossref
D. Sellami, B. Dharan, C. Wilke, S.J. Scherer & S. Hirawat. (2017) Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors. Annals of Oncology 28:11, pages 2882-2887.
Crossref
Maria Chimonidou, Areti Strati, Nikos Malamos, Sophia Kouneli, Vassilis Georgoulias & Evi Lianidou. (2017) Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer. Oncotarget 8:42, pages 72054-72068.
Crossref
Jing Gao, Haixing Wang, Wanchun Zang, Beifang Li, Guanhua Rao, Lei Li, Yang Yu, Zhongwu Li, Bin Dong, Zhihao Lu, Zhi Jiang & Lin Shen. (2017) Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer . Cancer Science 108:9, pages 1881-1887.
Crossref
Andreas Schröck, Annette Leisse, Luka de Vos, Heidrun Gevensleben, Freya Dröge, Alina Franzen, Malin Wachendörfer, Friederike Schröck, Joerg Ellinger, Marcus Teschke, Timo Wilhelm-Buchstab, Jennifer Landsberg, Stefan Holdenrieder, Gunther Hartmann, John K Field, Friedrich Bootz, Glen Kristiansen & Dimo Dietrich. (2017) Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study. Clinical Chemistry 63:7, pages 1288-1296.
Crossref
Lydia Giannopoulou, Issam Chebouti, Kitty Pavlakis, Sabine Kasimir-Bauer & Evi S. Lianidou. (2017) RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA . Oncotarget 8:13, pages 21429-21443.
Crossref
Akbar Khalilpour, Tugba Kilic, Saba Khalilpour, Mario Moisés Álvarez & Iman K. Yazdi. (2016) Proteomic-based biomarker discovery for development of next generation diagnostics. Applied Microbiology and Biotechnology 101:2, pages 475-491.
Crossref
Javier I. J. Orozco, Diego M. Marzese & Dave S. B. Hoon. 2017. Handbook of Nutrition, Diet, and Epigenetics. Handbook of Nutrition, Diet, and Epigenetics 1 21 .
Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong & Jimin Liang. (2016) Cell-free circulating tumor DNA in cancer. Chinese Journal of Cancer 35:1.
Crossref
Masahiro Kitahara, Shoichi Hazama, Ryouichi Tsunedomi, Hiroko Takenouchi, Shinsuke Kanekiyo, Yuka Inoue, Masao Nakajima, Shinobu Tomochika, Yoshihiro Tokuhisa, Michihisa Iida, Kazuhiko Sakamoto, Nobuaki Suzuki, Shigeru Takeda, Tomio Ueno, Shigeru Yamamoto, Shigefumi Yoshino & Hiroaki Nagano. (2016) Prediction of the efficacy of immunotherapy by measuring the integrity of cell‐free DNA in plasma in colorectal cancer . Cancer Science 107:12, pages 1825-1829.
Crossref
Paul Hofman & Helmut H. Popper. (2016) Pathologists and liquid biopsies: to be or not to be?. Virchows Archiv 469:6, pages 601-609.
Crossref
Yafang Liu, Ze Xing, Ping Zhan, Hongbing Liu, Wei Ye, Tangfeng Lv & Yong Song. (2016) Is it feasible to detect epidermal growth factor receptor mutations in circulating tumor cells in nonsmall cell lung cancer?. Medicine 95:47, pages e5115.
Crossref
C. Parisi, S. Mastoraki, A. Markou, A. Strati, M. Chimonidou, V. Georgoulias & E.S. Lianidou. (2016) Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis. Clinica Chimica Acta 461, pages 156-164.
Crossref
Quan Zhou, Wei Li, Bingjie Leng, Wenfei Zheng, Ze He, Manzhen Zuo & Aihua Chen. (2016) Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis. PLOS ONE 11:6, pages e0155495.
Crossref
Jian Chen, Wei Huan, Hao Zuo, Longxiang Zhao, Chuanjun Huang, Xiaojiang Liu, Shiqiang Hou, Jing Qi & Wei Shi. (2016) Alu methylation serves as a biomarker for non-invasive diagnosis of glioma. Oncotarget 7:18, pages 26099-26106.
Crossref
Sharon K. Huang & Dave S.B. Hoon. (2016) Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients. Molecular Oncology 10:3, pages 450-463.
Crossref
M. Giefing, M. Wierzbicka, K. Szyfter, J.C. Brenner, B.J. Braakhuis, R.H. Brakenhoff, C.R. Bradford, J.A. Sorensen, A. Rinaldo, J.P. Rodrigo, R.P. Takes & A. Ferlito. (2016) Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data. European Journal of Cancer 55, pages 147-157.
Crossref
Ioanna Balgkouranidou, Maria Chimonidou, Georgia Milaki, Emily Tsaroucha, Stylianos Kakolyris, Vasilis Georgoulias & Evi Lianidou. (2016) SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer. Clinical Chemistry and Laboratory Medicine (CCLM) 54:8.
Crossref
Shigeshi Ono, Stella Lam, Makoto Nagahara & Dave Hoon. (2015) Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays. Journal of Clinical Medicine 4:10, pages 1890-1907.
Crossref
Glenn Francis & Sandra Stein. (2015) Circulating Cell-Free Tumour DNA in the Management of Cancer. International Journal of Molecular Sciences 16:12, pages 14122-14142.
Crossref
Evelyn Kidess, Kyra Heirich, Matthew Wiggin, Valentina Vysotskaia, Brendan C. Visser, Andre Marziali, Bertram Wiedenmann, Jeffrey A. Norton, Mark Lee, Stefanie S. Jeffrey & George A. Poultsides. (2014) Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform. Oncotarget 6:4, pages 2549-2561.
Crossref
Detao Li, Fengzeng Li, Yanfeng Wu, Dandan Zhou & Hui Chen. (2015) Quantification of serum MET in non-small-cell lung cancer and its clinical significance. Clinical Biochemistry 48:3, pages 110-114.
Crossref
Dalong Pang, Alain R. Thierry & Anatoly Dritschilo. (2015) DNA studies using atomic force microscopy: capabilities for measurement of short DNA fragments. Frontiers in Molecular Biosciences 2.
Crossref
Rene Cortese, Isaac Almendros, Yang Wang & David Gozal. (2014) Tumor circulating DNA profiling in xenografted mice exposed to intermittent hypoxia. Oncotarget 6:1, pages 556-569.
Crossref
Giuseppe Lippi, Fabian Sanchis-Gomar & Gianfranco Cervellin. (2015) Cell-free DNA for diagnosing myocardial infarction: not ready for prime time. Clinical Chemistry and Laboratory Medicine (CCLM) 53:12.
Crossref
Eleonora Zonta, Philippe Nizard & Valérie Taly. 2015. 197 246 .
Evi S. Lianidou, Athina Markou & Areti Strati. 2015. Advances in Cancer Biomarkers. Advances in Cancer Biomarkers 341 367 .
Karina Dahl Steffensen, Christine Vestergaard Madsen, Rikke Fredslund Andersen, Marianne Waldstrøm, Parvin Adimi & Anders Jakobsen. (2014) Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab. European Journal of Cancer 50:15, pages 2611-2618.
Crossref
Alison S. Devonshire, Alexandra S. Whale, Alice Gutteridge, Gerwyn Jones, Simon Cowen, Carole A. Foy & Jim F. Huggett. (2014) Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification. Analytical and Bioanalytical Chemistry 406:26, pages 6499-6512.
Crossref
I Balgkouranidou, M Chimonidou, G Milaki, E G Tsarouxa, S Kakolyris, D R Welch, V Georgoulias & E S Lianidou. (2014) Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer. British Journal of Cancer 110:8, pages 2054-2062.
Crossref
Evi S Lianidou. (2014) Circulating Tumor Cell Isolation: A Marathon Race Worth Running. Clinical Chemistry 60:2, pages 287-289.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.